Sunriver Management LLC Grows Holdings in First Advantage Co. (NYSE:FA)

Sunriver Management LLC increased its position in shares of First Advantage Co. (NYSE:FA - Free Report) by 16.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,292,235 shares of the company's stock after acquiring an additional 315,598 shares during the period. First Advantage comprises about 5.1% of Sunriver Management LLC's portfolio, making the stock its 8th biggest position. Sunriver Management LLC owned about 1.33% of First Advantage worth $42,934,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Barclays PLC lifted its holdings in shares of First Advantage by 33.9% during the fourth quarter. Barclays PLC now owns 109,327 shares of the company's stock worth $2,048,000 after purchasing an additional 27,658 shares during the period. Summit Investment Advisors Inc. raised its position in shares of First Advantage by 15.3% during the fourth quarter. Summit Investment Advisors Inc. now owns 6,267 shares of the company's stock worth $117,000 after acquiring an additional 832 shares during the last quarter. CenterBook Partners LP lifted its stake in shares of First Advantage by 57.8% in the fourth quarter. CenterBook Partners LP now owns 195,324 shares of the company's stock worth $3,658,000 after acquiring an additional 71,560 shares during the period. Legal & General Group Plc boosted its holdings in First Advantage by 51.5% in the fourth quarter. Legal & General Group Plc now owns 93,109 shares of the company's stock valued at $1,744,000 after acquiring an additional 31,659 shares during the last quarter. Finally, Invesco Ltd. increased its position in First Advantage by 17.8% during the 4th quarter. Invesco Ltd. now owns 100,800 shares of the company's stock valued at $1,888,000 after purchasing an additional 15,229 shares during the period. Institutional investors own 94.91% of the company's stock.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the stock. Barclays restated an "equal weight" rating and issued a $15.00 price target (down previously from $20.00) on shares of First Advantage in a research report on Thursday, April 10th. BMO Capital Markets cut their price target on shares of First Advantage from $24.00 to $22.00 and set an "outperform" rating on the stock in a research report on Monday, March 3rd. William Blair reissued an "outperform" rating on shares of First Advantage in a research report on Friday, February 28th. Finally, Royal Bank of Canada restated an "outperform" rating and set a $22.00 target price on shares of First Advantage in a research report on Thursday, January 23rd. Four equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, First Advantage presently has a consensus rating of "Moderate Buy" and an average price target of $65.80.

First Advantage Stock Down 2.3 %

Shares of NYSE FA traded down $0.32 during trading on Friday, hitting $13.47. 993,097 shares of the company traded hands, compared to its average volume of 748,598. The company has a debt-to-equity ratio of 0.61, a quick ratio of 3.85 and a current ratio of 3.85. The business's fifty day moving average is $15.04 and its 200 day moving average is $17.51. The firm has a market capitalization of $2.34 billion, a price-to-earnings ratio of 449.00 and a beta of 1.20. First Advantage Co. has a fifty-two week low of $12.32 and a fifty-two week high of $20.79.

First Advantage Profile

First Advantage Corporation provides employment background screening, identity, and verification solutions worldwide. It offers pre-onboarding products and solutions, such as criminal background checks, drug/health screening, extended workforce screening, FBI channeling, identity checks and biometric fraud mitigation tools, education/work history verification, driver records and compliance, healthcare credentials, executive screening, and other screening products.